# Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram

> **NCT00613470** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 927 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** citalopram and escitalopram

## Key facts

- **NCT ID:** NCT00613470
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 927 (ACTUAL)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613470, "Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00613470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*